Basit öğe kaydını göster

Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial

dc.contributor.authorZeymer, Uwe
dc.contributor.authorLeiva, Orly
dc.contributor.authorHohnloser, Stefan H.
dc.contributor.authorSteg, Philippe Gabriel
dc.contributor.authorOldgren, Jonas
dc.contributor.authorOngen, Zeki
dc.contributor.authorEstrada, Jose Navarro
dc.contributor.authorOphuis, Ton Oude
dc.contributor.authorLip, Gregory Y. H.
dc.contributor.authorNordaby, Matias
dc.contributor.authorMiede, Corinna
dc.contributor.authorten Berg, Jurrien M.
dc.contributor.authorBhatt, Deepak L.
dc.contributor.authorCannon, Christopher P.
dc.contributor.authorNickenig, Georg
dc.contributor.authorKiss, Robert Gabor
dc.date.accessioned2021-12-10T11:46:37Z
dc.date.available2021-12-10T11:46:37Z
dc.date.issued2021
dc.identifier.citationZeymer U., Leiva O., Hohnloser S. H. , Steg P. G. , Oldgren J., Nickenig G., Kiss R. G. , Ongen Z., Estrada J. N. , Ophuis T. O. , et al., "Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial", EUROINTERVENTION, cilt.17, sa.6, ss.474-483, 2021
dc.identifier.issn1774-024X
dc.identifier.otherav_94009eb4-5469-40b6-8643-0363ece5c662
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/172607
dc.identifier.urihttps://doi.org/10.4244/eij-d-20-00799
dc.description.abstractBackground: Little is known about the optimal antithrombotic therapy in patients with atrial fibrillation undergoing PCI for ST-elevation myocardial infarction (STEMI).
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectKardiyoloji
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleDual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial
dc.typeMakale
dc.relation.journalEUROINTERVENTION
dc.contributor.departmentKlinikum Ludwigshafen & Inst Herzinfarktforsch , ,
dc.identifier.volume17
dc.identifier.issue6
dc.identifier.startpage474
dc.identifier.endpage483
dc.contributor.firstauthorID2721737


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster